Cellular plasticity: the good, the bad, and the ugly? Microenvironmental influences on progenitor cell therapy

Jan-Renier A. J. Moonen, Martin C. Harmsen*, Guido Krenning

*Corresponding author voor dit werk

Onderzoeksoutputpeer review

11 Citaten (Scopus)

Samenvatting

Progenitor cell based therapies have emerged for the treatment of ischemic cardiovascular diseases where there is insufficient endogenous repair. However, clinical success has been limited, which challenges the original premise that transplanted progenitor cells would orchestrate repair. In this review, we discuss the basics of endothelial progenitor cell therapy and describe how microenvironmental changes (i.e., trophic and mechano-structural factors) in the damaged myocardium influence progenitor cell plasticity and hamper beneficial therapeutic outcome. Further understanding of these microenvironmental clues will enable optimization of cell therapy at all levels. We discuss current concepts and provide future perspectives for the enhancement of progenitor cell therapy, and merge these advances into a combined approach for ischemic tissue repair.

Originele taal-2English
Pagina's (van-tot)275-285
Aantal pagina's11
TijdschriftCanadian journal of physiology and pharmacology
Volume90
Nummer van het tijdschrift3
DOI's
StatusPublished - mrt.-2012

Vingerafdruk

Duik in de onderzoeksthema's van 'Cellular plasticity: the good, the bad, and the ugly? Microenvironmental influences on progenitor cell therapy'. Samen vormen ze een unieke vingerafdruk.

Citeer dit